- Full Year 2023 AddLife AB Earnings Call TranscriptFeb 02, 2024$42Earnings
- Q3 2023 AddLife AB Earnings Call TranscriptOct 26, 2023$42Earnings
- AddLife AB Capital Markets Day TranscriptSep 15, 2023
- Q2 2023 AddLife AB Earnings Call TranscriptJul 14, 2023$42Earnings
- Q1 2023 AddLife AB Earnings Call TranscriptApr 26, 2023$42Earnings
- Full Year 2022 AddLife AB Earnings Call TranscriptFeb 02, 2023$42Earnings
- Q3 2022 AddLife AB Earnings Call TranscriptOct 27, 2022$42Earnings
- Q2 2022 AddLife AB Earnings Call TranscriptJul 15, 2022$42Earnings
- Q1 2022 AddLife AB Earnings Call TranscriptApr 28, 2022$42Earnings
- Q4 2021 AddLife AB Earnings Call TranscriptFeb 04, 2022$42Earnings
- Nine Months 2021 AddLife AB Earnings Call TranscriptOct 22, 2021$17.38Earnings
- Half Year 2021 AddLife AB Earnings Call TranscriptJul 15, 2021$17.38Earnings
- Q1 2021 AddLife AB Earnings Call TranscriptApr 28, 2021$17.38Earnings
- AddLife AB acquires Healthcare 21 Group Call TranscriptApr 12, 2021
- AddLife AB Acquisition of Vision Ophthalmology Group GmbH Conference Call TranscriptApr 08, 2021
- Full Year 2020 AddLife AB Earnings Call TranscriptFeb 03, 2021$17.38Earnings
- Nine Months 2020 AddLife AB Earnings Call TranscriptOct 21, 2020$17.75Earnings
- Half Year 2020 AddLife AB Earnings Call TranscriptJul 17, 2020$7.8Earnings
- Q1 2020 AddLife AB Earnings Call TranscriptApr 28, 2020$7.8Earnings
- Full Year 2019 AddLife AB Earnings Call TranscriptFeb 06, 2020$7.8Earnings
- Half Year 2019 AddLife AB Earnings Call TranscriptJul 12, 2019$6.25Earnings
- Q1 2019 AddLife AB Earnings Call TranscriptMay 10, 2019$6.25Earnings
Q3 2023 AddLife AB Earnings Call Transcript
()-&
Good morning everyone, and welcome to the Add Life third quarter presentation. Today we will go through some of the business highlights as well as the financials. And then we will open up for questions and discussions.
We're very happy to report a strong growth in the quarter. All the companies are performing very, very well. And in the Labtech business area, we have a 9% organic currency adjusted growth; and in the Medtech business area, 10% organic growth.
We see the healthy demand in all the segments in which we are active. The increased activity in elective surgery remains strong, and we expect that trend to continue in the coming quarters. Positive market trends are supporting our business in home care, in diagnostics and in research. The EBITDA improved, making adjustments for contingent considerations. And that is true in spite of the fact that we have some negative impact from the profitability in AddVision.
The cash flow is significantly improving. We are releasing
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)